[Federal Register Volume 61, Number 148 (Wednesday, July 31, 1996)] [Notices] [Page 39987] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-19444] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Manufacturer of Controlled Substances; Notice of Registration By Notice dated April 9, 1996, and published in the Federal Register on April 19, 1996, (61 FR 17322), Knoll Pharmaceuticals, 30 North Jefferson Road, Whippany, New Jersey 07981, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of hydromorphone (9150), a basic class of controlled substance listed in Schedule II. No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Knoll Pharmaceuticals to manufacture hydromorphone is consistent with the public interest at this time. Therefore, pursuant to 21 U.S.C. Sec. 823 and 28 CFR Secs. 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic class of controlled substance listed above is granted. Dated: July 25, 1996. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 96-19444 Filed 7-30-96; 8:45 am] BILLING CODE 4410-09-M